mad cow disease (bovine
spongiform encephalopathy;
BSE) 316
major histocompatability complex
(MHC) 193, 253, 267, 282,
282
malaria 275, 342–343, 343 t, 350
MALT. Seemucosa-associated
lymphoid tissue
Marfan syndrome 11, 37, 59, 63
mast cell 283
allergic asthma 240
allergic rhinitis 243
antihistamine medications 247
corticosteroid medications 256
desensitization 258
food allergies 260, 261
histamine 266
hypersensitivity reaction 268
immune system 236
leukotrienes 279
SALT 295
measles 253, 303, 304, 343, 350
mechanical ventilation 214–215
medications to treat cardiovascular
disease 67, 76–84, 77 t–86t
meditation 92, 94, 205, 208
megakaryocyte 119, 163
memory B-cells 246, 251
memory T-cells 253, 296
meningitis 256, 318, 342, 343–344,
349
menopause 9, 10, 381
metabolism 7–9, 24, 33, 326
metastasis 120, 149, 151, 152, 384,
390, 391
methemoglobinemia 156–157
methotrexate 258, 259, 270
MHC. Seemajor histocompatability
complex
microbe 344
microinfarction 84
microscopic polyangiitis 300t
mind-body interactions 290, 387
minerals and health 50, 118–119
minimally invasive cardiac surgery
86, 394
mini-stroke. Seetransient ischemic
attack
modes of transmission. See
transmission modes
mold 271, 279, 327
molecularly targeted therapies 368,
384, 384, 384 t, 397
monoclonal antibodies (MAbs)
283, 283 t
cancer treatment options and
decisions 372
DMARDs 258
graft vs.host disease 264
hypersensitivity reaction 270
immune system 238
immunotherapy 277
oncogenes 384
TNFs 297
tumor suppressor genes 397
monocyte 157
granulocyte 139
human ehrlichiosis 335
immune response 272
leukocyte 119–120
lymph 120
lymphocyte 152
macrophage 282
monokines 283
phagocytosis 162
monokines 283
mononuclear phagocyte system
162, 167, 282, 283–284
mononucleosis, infectious 275,
303, 323, 344–345
mosquito bites 322, 324, 342
mouth 197, 315, 332, 336, 346
mucocutaneous lymph node
syndrome. SeeKawasaki disease
mucosa 287–288, 319
mucosa-associated lymphoid tissue
(MALT) 284
aging, effects on immune
response 239
allergic rhinitis 242
Epstein-Barr virus 324
immune system 235, 236
immunoglobulin 275
Peyer’s patches 289
T-cell lymphocyte 296
mucous membranes 283, 294–295,
306, 349
mucus 199, 202, 231, 233, 287
multiple chemical sensitivity
syndrome 190, 223, 284–285
multiple myeloma 138, 148, 152,
157–160, 158 t,372, 384
mumps 345
mutation
adenocarcinoma 366
BRCA-1/BRCA-2 369
cancer 364
congenital heart disease 38
LQTS 74–75
oncogenes 384
thalassemia 170tumor suppressor genes 397
myasthenia gravis 120–121, 172
Mycobacterium tuberculosis269, 305,
359, 360
myelodysplasia syndrome 160
myelofibrosis 160–161, 164
myeloma 275, 283
myocardial cells 74–75, 81, 82, 88,
111
myocardial infarction 86–87
angina pectoris 12
apoB100 16–17
cardiac enzymes 29
cardiomyopathy 32
heart attack 56
heart sounds 60
LVEF 72
sudden cardiac death 108
thrombolytic therapy 110, 111
myocardial perfusion imaging 87
myocarditis 31, 87–88, 322
myocardium 88, 88 t
angina pectoris 11, 12
aorta 16
cardiac enzymes 29
heart 4
medications to treat
cardiovascular disease 79
myocardial infarction 86
myocardial perfusion imaging 87
TMLR 112
myxoma 88N
NALT. Seenose-associated lymphoid
tissue
naphthoquinone. Seevitamin K
narrow therapeutic index (NTI)
14–15, 76–78, 81, 83, 375
nasal mucosa 243, 319
natural immunity. Seeinnate
immunity
natural killer (NK) cell 286
cell-mediated immunity 253
hypersensitivity reaction 268
immune response 272
immune system 236
immunotherapy 276
interferons 278
lymphocyte 151
nausea 57, 326, 352, 376, 387
necrotizing fasciitis 346, 357
Neisseria gonorrhoeae
nerve roots 316, 328, 332
nervous system 63, 273, 355
neuritis 322, 345Index 421329, 330